Premium Information is available for this item - Upgrade for $1 a day
6505-01-374-2024
Usp Lidocaine Hydrochloride Injection
6505013742024 013742024 4698-01 NDC00074-4698-01
INC: 10155 Lidocaine Hydrochloride Injection
January 2023
4
Marketplace 6505-01-374-2024
Request a Quotation from participating marketplace vendors
Related Documents 6505-01-374-2024 5+ Documents (More...)
RQST NE Updated Every Day 6505-01-374-2024 RQST Updated Every Day 6505-01-374-2024 RQST NE Related Documents
6505-01-374-2024 5+ Documents ( More... ) https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-2024
Usp Lidocaine Hydrochloride Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-2024 https
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-680-2094 Usp Lidocaine Hydrochloride Injection LIDOCAINE 6505-01-374-2024
Usp Lidocaine Hydrochloride Injection 45126505001394512001394512 LIDOCAINE 6505-01-374-2024 https
www.nsnlookup.com /fsg-65/fsc-6505/us 6505-00-334-3461 Lidocaine Hydrochloride Injection 003343461 6505/us 6505-01-374-2024
Usp Lidocaine Hydrochloride Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-2024 https
Related Documents 6505-00-139 https Hydrochloride Injection www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-2024
65/fsc-6505/nl 6505-17-111-1816 Lidocaine Hydrochloride Injection 171111816 6505-00-957-8096 6505-01-374-2024
6505 Hydrochloride Injection 171057121 171111816 https//www.nsnlookup.com /fsg-65/fsc-6505/us 6505-01-374-2024
Restrictions 6505-01-374-2024
6505-01-374-2024 is a Usp Lidocaine Hydrochloride Injection that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item may be hazardous as it is in a Federal Supply Class for potentially hazardous items. A MSDS should be available from the supplier for the end user to evaluate any hazards. The precious metals content of this item is unknown.
Import and Export 6505-01-374-2024
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6505-01-374-2024
- MOE Rule:
- V540
- Effective Date:
- 1 Apr 1991
Approved Sources 6505-01-374-2024
- Part Number
- Manufacturer
- Status
- 4698-01
- Manufacturer
- 0DJW4 - Abbott Laboratories (Obsolete)
- Primary Buy
- Primary Buy
- NDC00074-4698-01
- 0DJW4 - Abbott Laboratories (Obsolete)
- Primary Buy
- Primary Buy
Datasheet 6505-01-374-2024
- Characteristic
- Specifications
- FIIG
- Specifications
- A45100
- Active Medicament Medicinal Strength [AKJA]
- 4.000 Percentage, W/V Lidocaine Hydrochloride Active Ingredient
- Primary Container Type [CQCT]
- Vial Injector Unit
- Primary Container Content Quantity [CRLK]
- 4.000 Milliliters
- Total Primary Container Quantity [CSCW]
- 25
- Special Features [FEAT]
- Vial Is Preattached To Injector And Anatomically Designed Cannula
Similar Supply Items to 6505-01-374-2024
Freight Information 6505-01-374-2024
6505-01-374-2024 has freight characteristics.. 6505-01-374-2024 has a variance between NMFC and UFC when transported by rail and the description should be consulted.